Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04889521 · ClinicalTrials.gov registry record
Neuropathy Walks (Cross-sectional)
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 75
- Enrollment target
NCT04889521: Completed study, sponsored by Rutgers, The State University of New Jersey.
NCT04889521 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04889521 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Cross-sectional study is to explore the impact of painful neuropathy in the feet on function in persons living with HIV (PLHIV).
Primary Outcome
Temporal characteristic of gait measured in m/sec as captured with a ZENO instrumented walkway
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2024-09-13 |
What the finished NCT04889521 record still lists
NCT04889521 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04889521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04889521 about?
NCT04889521 is a clinical study titled "Neuropathy Walks (Cross-sectional)". Cross-sectional study is to explore the impact of painful neuropathy in the feet on function in persons living with HIV (PLHIV).
What is the current status of trial NCT04889521?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2022-04-22. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT04889521?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04889521?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI